Not Rated
Fund Size
(0.27% of Investment in Category)
|
Expense Ratio
(2.08% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 15-Jan-25 | 9933.00 | -0.67% | - | -0.98% | 95/214 |
1 Month | 20-Dec-24 | 9662.00 | -3.38% | - | -4.79% | 55/209 |
3 Month | 22-Oct-24 | 9903.90 | -0.96% | - | -5.99% | 23/198 |
6 Month | 22-Jul-24 | 11182.30 | 11.82% | - | -4.86% | 8/186 |
YTD | 01-Jan-25 | 9418.10 | -5.82% | - | -5.18% | 133/215 |
1 Year | 19-Jan-24 | 13083.00 | 30.83% | 30.45% | 13.83% | 5/162 |
2 Year | 20-Jan-23 | 18772.40 | 87.72% | 36.84% | 23.64% | 7/134 |
3 Year | 21-Jan-22 | 17348.30 | 73.48% | 20.12% | 15.93% | 31/124 |
5 Year | 22-Jan-20 | 31352.80 | 213.53% | 25.65% | 19.83% | 19/102 |
10 Year | 22-Jan-15 | 31431.30 | 214.31% | 12.12% | 12.93% | 45/73 |
Since Inception | 30-Jul-05 | 152535.10 | 1425.35% | 15.00% | 11.55% | 79/185 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 19-Jan-24 | 12000 | 13467.39 | 12.23 % | 23.2 % |
2 Year | 20-Jan-23 | 24000 | 33653.3 | 40.22 % | 36.13 % |
3 Year | 21-Jan-22 | 36000 | 55830.33 | 55.08 % | 30.58 % |
5 Year | 22-Jan-20 | 60000 | 108491.11 | 80.82 % | 23.88 % |
10 Year | 22-Jan-15 | 120000 | 298984.04 | 149.15 % | 17.37 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 1367.6 | 11.07% | 0.34% | 13.91% (Feb 2024) | 11.29% (Oct 2024) | 7.25 L | 0.00 |
- Cipla Ltd. | Pharmaceuticals | 710.9 | 5.75% | 0.00% | 7.77% (Feb 2024) | 5.89% (Oct 2024) | 4.65 L | 14.29 k |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 652.9 | 5.28% | 0.58% | 6.69% (Nov 2023) | 4.67% (Oct 2024) | 4.70 L | 0.00 |
Ajanta Pharma Limited | Pharmaceuticals | 566.1 | 4.58% | -0.27% | 5.95% (May 2024) | 4.97% (Nov 2023) | 1.93 L | 0.00 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 497.7 | 4.03% | 0.10% | 3.71% (Aug 2024) | 0% (Nov 2023) | 3.09 L | 0.00 |
Gland Pharma Ltd. | Pharmaceuticals | 473.9 | 3.83% | -0.02% | 3.7% (Oct 2024) | 2.5% (Nov 2023) | 2.66 L | 0.00 |
Apollo Hospitals Enterprises Ltd. | Hospital | 437.8 | 3.54% | 0.13% | 7.12% (Jan 2024) | 3.55% (Oct 2024) | 60.00 k | 0.00 |
Fortis Healthcare Ltd. | Hospital | 401.5 | 3.25% | -0.10% | 4.59% (Nov 2023) | 2.93% (Jul 2024) | 5.58 L | -0.54 L |
Procter & Gamble Health Ltd. | Pharmaceuticals | 387.6 | 3.14% | -0.04% | 3.79% (Jun 2024) | 1.95% (Jan 2024) | 74.00 k | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 375 | 3.03% | -0.12% | 3.38% (Nov 2023) | 2.35% (Mar 2024) | 61.48 k | 0.00 |
Investment / Portfolio Grades
Security Type |
% Weight |
Category Average |
---|---|---|
Government Backed | 0.10% | 0.31% |
Low Risk | 0.00% | 0.00% |
Moderate Risk | 0.00% | 0.00% |
High Risk | 0.00% | 0.00% |
Very High Risk | 0.00% | 0.00% |
Others | 0.00% | 0.00% |
Name | Type of Instrument | Weight (%) |
---|---|---|
Net Receivables | Net Receivables | 2.31% |
Margin | Margin | 0.01% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st December, 2024)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth | NA | 5320.29 | -2.34 | -0.39 | 12.26 | 33.91 | 23.90 |
DSP Healthcare Fund - Regular Plan - Growth | NA | 3339.79 | -0.44 | 0.28 | 14.54 | 32.32 | 22.36 |
LIC MF Healthcare Fund - Regular Plan - Growth | NA | 86.26 | -3.25 | -1.11 | 12.23 | 31.39 | 17.09 |
LIC MF Infrastructure Fund - Growth | 4 | 927.50 | -8.81 | -4.89 | -7.03 | 30.49 | 26.54 |
SBI Healthcare Opportunities Fund - Regular Plan - Growth | NA | 3628.03 | -2.13 | 1.39 | 13.79 | 29.82 | 23.13 |
ITI Pharma & Healthcare Fund - Regular Plan - Growth | NA | 230.79 | -4.42 | -1.27 | 10.33 | 27.26 | 18.15 |
Kotak Healthcare Fund - Regular Plan - Growth | NA | 439.02 | -3.83 | 0.15 | 10.62 | 27.23 | 0.00 |
Quant Commodities Fund - Regular Plan - Growth | NA | 427.02 | -4.81 | -6.68 | -4.18 | 27.04 | 0.00 |
Tata India Pharma & Heathcare Fund - Growth | NA | 1287.45 | -3.36 | -1.74 | 8.35 | 26.90 | 20.49 |
Mirae Asset Healthcare Fund - Growth | NA | 2863.52 | -3.09 | -3.06 | 7.97 | 26.63 | 17.64 |
Out of 95 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 11 is/are ranked 4 * , 9 is/are ranked 3 * , 8 is/are ranked 2 * , 2 is/are ranked 1 * , and 62 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
UTI Nifty 50 ETF | 4 | 57902.18 | -1.74 | -5.17 | -5.09 | 8.49 | 10.77 |
UTI Nifty 50 ETF | 4 | 57902.18 | -1.74 | -5.17 | -5.09 | 8.49 | 10.77 |
UTI BSE Sensex ETF | 5 | 44121.79 | -2.08 | -4.61 | -4.73 | 8.10 | 10.28 |
UTI BSE Sensex ETF | 5 | 44121.79 | -2.08 | -4.61 | -4.73 | 8.10 | 10.28 |
UTI Flexi Cap Fund - Growth | 1 | 26062.33 | -4.97 | -4.73 | -1.70 | 11.64 | 4.88 |
UTI Liquid Fund - Regular Plan - Growth | 2 | 23764.36 | 0.59 | 1.73 | 3.52 | 7.29 | 6.46 |
UTI Nifty 50 Index Fund - Growth | 4 | 20010.28 | -1.76 | -5.23 | -5.20 | 8.70 | 10.44 |
UTI Nifty 50 Index Fund - Growth | 4 | 20010.28 | -1.74 | -5.16 | -5.06 | 8.59 | 10.84 |
UTI Money Market Fund - Regular Plan - Growth | 3 | 15370.41 | 0.63 | 1.77 | 3.65 | 7.63 | 6.74 |
UTI Large Cap Fund - Growth | 2 | 12616.62 | -1.83 | -5.13 | -5.27 | 9.45 | 8.57 |